Antioxidants from black and green tea: from dietary modulation of oxidative stress to pharmacological mechanisms

British Journal of Pharmacology

Volumn 174, Issue 11, 2017, Pages 1195-1208

  Peluso, Ilaria ^a   Serafini, Mauro ^a  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE; AMYLASE; EPIGALLOCATECHIN GALLATE; FLAVANOL DERIVATIVE; GLUCOSE TRANSPORTER; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; ORGANIC ANION TRANSPORTER; PROTON COUPLED FOLATE TRANSPORTER; TRIACYLGLYCEROL LIPASE; XANTHINE OXIDASE; ANTIOXIDANT; BIFLAVONOID; CATECHIN; THEAFLAVIN;

ANTIOXIDANT ACTIVITY; CAMELLIA SINENSIS; CHEMICAL STRUCTURE; DIETARY INTAKE; DIETARY SUPPLEMENT; ENZYME INHIBITION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; LIPID METABOLISM; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; TEA; ANIMAL; CARDIOVASCULAR DISEASE; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; NEOPLASM; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIOXIDANTS; BIFLAVONOIDS; CARDIOVASCULAR DISEASES; CATECHIN; HUMANS; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; TEA;

EID: 85001735599     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13649     Document Type: Review

References (144)

1. Alemdaroglu NC, Dietz U, Wolffram S, Spahn-Langguth H, Langguth P (2008). Influence of green and black tea on folic acid pharmacokinetics in healthy volunteers: potential risk of diminished folic acid bioavailability. Biopharm Drug Dispos 29: 335–348.
2. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
3. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Transporters. Br J Pharmacol 172: 6110–6202.
4. Arts IC, van De Putte B, Hollman PC (2000). Catechin contents of foods commonly consumed in the Netherlands. 2. Tea, wine, fruit juices and chocolate milk. J Agric Food Chem 48: 1752–1757.
5. Aucamp J, Gaspar A, Hara Y, Apostolides Z (1997). Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis). Anticancer Res 17 (6D): 4381–4385.
6. Ayrton A, Morgan P (2001). Role of transport proteins in drug absorption, distribution and excretion. Xenobiotica 31: 469–497.
7. Bahorun T, Luximon-Ramma A, Gunness TK, Sookar D, Bhoyroo S, Jugessur R et al. (2010). Black tea reduces uric acid and C-reactive protein levels in humans susceptible to cardiovascular diseases. Toxicology 278: 68–74.
8. Begona Barroso M, Werken van de G (1999). Determination of green and black tea composition by capillary electrophoresis. J High Resolut Chrom 22: 225–230.
9. Bertipaglia de Santana M, Mandarino MG, Cardoso JR, Dichi I, Dichi JB, Camargo AE et al. (2008). Association between soy and green tea (Camellia sinensis) diminishes hypercholesterolemia and increases total plasma antioxidant potential in dyslipidemic subjects. Nutrition 24: 562–568.
10. Boušová I, Hájek J, Dršata J, Skálová L (2012). Naturally occurring flavonoids as inhibitors of purified cytosolic glutathione S-transferase. Xenobiotica 42: 872–879.
11. Braga M, Bissolati M, Rocchetti S, Beneduce A, Pecorelli N, Di Carlo V (2012). Oral preoperative antioxidants in pancreatic surgery: a double-blind, randomized, clinical trial. Nutrition 28: 160–164.
12. Bronner WE, Beecher GR (1998). Method for determining the content of catechins in tea infusions by high-performance liquid chromatography. J Chromatogr A 805: 137–142.
13. Bunchorntavakul C, Reddy KR (2013). Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther 37: 3–17.
14. Chow HH, Hakim IA, Vining DR, Crowell JA, Cordova CA, Chew WM et al. (2006). Effects of repeated green tea catechin administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev 15: 2473–2476.
15. Clifford MN, van der Hooft JJ, Crozier A (2013). Human studies on the absorption, distribution, metabolism, and excretion of tea polyphenols. Am J Clin Nutr 98 (6 Suppl): 1619S–1630S.
16. Cuccioloni M, Mozzicafreddo M, Spina M, Tran CN, Falconi M, Eleuteri AM et al. (2011). Epigallocatechin-3-gallate potently inhibits the in vitro activity of hydroxy-3-methyl-glutaryl-CoA reductase. J Lipid Res 52: 897–907.
17. Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ et al. (2003). Black tea consumption reduces total and LDL cholesterol in mildly hypercholesterolemic adults. J Nutr 133: 3298S–3302S.
18. Del Rio D, Rodriguez-Mateos A, Spencer JP, Tognolini M, Borges G, Crozier A (2013). Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid Redox Signal 18: 1818–1892.
19. Dew TP, Day AJ, Morgan MR (2005). Xanthine oxidase activity in vitro: effects of food extracts and components. J Agric Food Chem 53: 6510–6515.
20. Di Lorenzo C, Ceschi A, Kupferschmidt H, Lüde S, De Souza NE, Dos Santos A et al. (2015). Adverse effects of plant food supplements and botanical preparations: a systematic review with critical evaluation of causality. Br J Clin Pharmacol 79: 578–592.
21. Ding M, Yang H, Xiao S (1999). Rapid, direct determination of polyphenols in tea by reversed-phase column liquid chromatography. J Chromatogr A 849: 637–640.
22. Ding Z, Kuhr S, Engelhardt UH (1992). Influence of catechins and theaflavins on the astringent taste of black tea brews. Zeitschrift fuer Lebensmittel Untersuchung und Forschung 195: 108–111.
23. Donovan JL, Chavin KD, Devane CL, Taylor RM, Wang JS, Ruan Y et al. (2004). Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Dispos 32: 906–908.
24. Donovan JL, DeVane CL, Chavin KD, Oates JC, Njoku C, Patrick KS et al. (2005). Oral administration of a decaffeinated green tea (Camellia sinensis) extract did not alter urinary 8-epi-prostaglandin F(2 alpha), a biomarker for in-vivo lipid peroxidation. J Pharm Pharmacol 57: 1365–1369.
25. Du Y, Wu Y, Cao X, Cui W, Zhang H, Tian W et al. (2009). Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions. Biochimie 91: 434–444.
26. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, Lu H et al. (2003). Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63: 7563–7570.
27. Feng WY (2006). Metabolism of green tea catechins: an overview. Curr Drug Metab 7: 755–809.
28. Forester SC, Gu Y, Lambert JD (2012). Inhibition of starch digestion by the green tea polyphenol, (−)-epigallocatechin-3-gallate. Mol Nutr Food Res 56: 1647–1654.
29. Freese R, Basu S, Hietanen E, Nair J, Nakachi K, Bartsch H et al. (1999). Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. Eur J Nutr 38: 149–157.
30. Fuchikami H, Satoh H, Tsujimoto M, Ohdo S, Ohtani H, Sawada Y (2006). Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos 34: 577–582.
31. Ghosh KS, Maiti TK, Dasgupta S (2004). Green tea polyphenols as inhibitors of ribonuclease A. Biochem Biophys Res Commun 325: 807–811.
32. Gomikawa S, Ishikawa Y, Hayase W, Haratake Y, Hirano N, Matuura H et al. (2008). Effect of ground green tea drinking for 2 weeks on the susceptibility of plasma and LDL to the oxidation ex vivo in healthy volunteers. Kobe J Med Sci 54: E62–E72.
33. Grove KA, Sae-tan S, Kennett MJ, Lambert JD (2012). (−)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Obesity (Silver Spring) 20: 2311–2313.
34. Hartley L, Flowers N, Holmes J, Clarke A, Stranges S, Hooper L et al. (2013) Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. Jun 18; 6:CD009934.
35. Hirano-Ohmori R, Takahashi R, Momiyama Y, Taniguchi H, Yonemura A, Tamai S et al. (2005). Green tea consumption and serum malondialdehyde-modified LDL concentrations in healthy subjects. J Am Coll Nutr 24: 342–346.
36. Hodgson JM, Croft KD, Mori TA, Burke V, Beilin LJ, Puddey IB (2002a). Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. J Nutr 132: 55–58.
37. Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ (2002b). Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond) 102: 195–201.
38. Hu QH, Zhang X, Wang X, Jiao RQ, Kong LD (2012). Quercetin regulates organic ion transporter and uromodulin expression and improves renal function in hyperuricemic mice. Eur J Nutr 51: 593–606.
39. Huang YQ, Lu X, Min H, Wu QQ, Shi XT, Bian KQ et al. (2016). Green tea and liver cancer risk: a meta-analysis of prospective cohort studies in Asian populations. Nutrition 32: 3–8.
40. Hursel R, Janssens PL, Bouwman FG, Mariman EC, Westerterp-Plantenga MS (2014). The role of catechol-O-methyl transferase Val(108/158)Met polymorphism (rs4680) in the effect of green tea on resting energy expenditure and fat oxidation: a pilot study. PLoS One 9: e106220. doi:10.1371/journal.pone.0106220.eCollection 2014
41. Ikeda I, Tsuda K, Suzuki Y, Kobayashi M, Unno T, Tomoyori H et al. (2005). Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. J Nutr 135: 155–159.
42. Isomura T, Suzuki S, Origasa H, Hosono A, Suzuki M, Sawada T et al. (2016). Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials. Eur J Clin Nutr. doi:10.1038/ejcn.2016.78.
43. Jaiyen C, Jutabha P, Anzai N, Lungkaphin A, Soodvilai S, Srimaroeng C (2015). Interaction of green tea catechins with renal organic cation transporter 2. Xenobiotica 17: 1–10.
44. Johnston K, Sharp P, Clifford M, Morgan L (2005). Dietary polyphenols decrease glucose uptake by human intestinal Caco-2 cells. FEBS Lett 579: 1653–1657.
45. Khalesi S, Sun J, Buys N, Jamshidi A, Nikbakht-Nasrabadi E, Khosravi-Boroujeni H (2014). Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr 53: 1299–1311.
46. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H (2006). Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate. Cancer Res 66: 2500–2505.
47. Khokhar S, Magnusdottir SG (2002). Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem 50: 565–570.
48. Kilmartin PA, Chyong FH (2003). Characterisation of polyphenols in green, oolong, and black teas, and in coffee, using cyclic voltammetry. Food Chem 82: 501–512.
49. Kim YH, Won YS, Yang X, Kumazoe M, Yamashita S, Hara A et al. (2016). Green tea catechin metabolites exert immunoregulatory effects on CD4(+) T cell and natural killer cell activities. J Agric Food Chem 64: 3591–3597.
50. Kimura M, Umegaki K, Kasuya Y, Sugisawa A, Higuchi M (2002). The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr 56: 1186–1193.
51. Kissei M, Itoh T, Narawa T (2014). Effect of epigallocatechin gallate on drug transport mediated by the proton-coupled folate transporter. Drug Metab Pharmacokinet 29: 367–372.
52. Kitagawa S, Nabekura T, Kamiyama S (2004). Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J Pharm Pharmacol 56: 1001–1005.
53. Knop J, Misaka S, Singer K, Hoier E, Müller F, Glaeser H et al. (2015). Inhibitory effects of green tea and (−)-epigallocatechin gallate on transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein. PLoS One 10: e0139370.
54. Kobayashi M, Ichitani M, Suzuki Y, Unno T, Sugawara T, Yamahira T et al. (2009). Black-tea polyphenols suppress postprandial hypertriacylglycerolemia by suppressing lymphatic transport of dietary fat in rats. J Agric Food Chem 57: 7131–7136.
55. Kobayashi Y, Suzuki M, Satsu H, Arai S, Hara Y, Suzuki K et al. (2000). Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism. J Agric Food Chem 48: 5618–5623.
56. Kuhr S, Engelhardt UH (1991). Determination of flavanols, theogallin. Zeitschrift fuer Lebensmittel Untersuchung und Forschung 192: 526–529.
57. Lambert JD, Elias RJ (2010). The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 501: 65–72.
58. Lee BL, Ong CN (2000). Comparative analysis of tea catechins and theaflavins by high-performance liquid chromatography and capillary electrophoresis. J Chromatogr A 881: 439–447.
59. Lee DH, Kim YJ, Kim HH, Cho HJ, Ryu JH, Rhee MH et al. (2013). Inhibitory effects of epigallocatechin-3-gallate on microsomal cyclooxygenase-1 activity in platelets. Biomol Ther (Seoul) 21: 54–59.
60. Lettieri-Barbato D, Tomei F, Sancini A, Morabito G, Serafini M (2013). Effect of plant foods and beverages on plasma non-enzymatic antioxidant capacity in human subjects: a meta-analysis. Br J Nutr 109: 1544–1556.
61. Li L, Chen CY, Aldini G, Johnson EJ, Rasmussen H, Yoshida Y et al. (2010). Supplementation with lutein or lutein plus green tea extracts does not change oxidative stress in adequately nourished older adults. J Nutr Biochem 21: 544–549.
62. Li Y, Wang C, Huai Q, Guo F, Liu L, Feng R et al. (2016). Effects of tea or tea extract on metabolic profiles in patients with type 2 diabetes mellitus: a meta-analysis of ten randomized controlled trials. Diabetes Metab Res Rev 32: 2–10.
63. Liang Y, Lu J, Zhang L, Wu S, Wu Y (2003). Estimation of black tea quality by analysis of chemical composition and colour difference of tea infusion. Food Chem 80: 283–290.
64. Lin JK, Chen PC, Ho CT, Lin-Shiau SY (2000). Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3′-digallate, (−)-epigallocatechin-3-gallate, and propyl gallate. J Agric Food Chem 48: 2736–2743.
65. Lin JK, Lin CL, Liang YC, Lin-Shiau SY, Juan IM (1998). Survey of catechins, gallic acid, and methylxanthines in green, oolong, pu-erh and black teas. J Agric Food Chem 46: 3635–3642.
66. Lin Y, Juan I, Chen Y, Liang Y, Lin J (1996). Composition of polyphenols in fresh tea leaves and associations of their oxygen-radical-absorbing capacity with antiproliferative actions in fibroblast cells. J Agric Food Chem 44: 1387–1394.
67. Lisowska A, Stawińska-Witoszyńska B, Bajerska J, Krzyżanowska P, Walkowiak J (2015). Green tea influences intestinal assimilation of lipids in humans: a pilot study. Eur Rev Med Pharmacol Sci 19: 209–214.
68. Liu K, Zhou R, Wang B, Chen K, Shi LY, Zhu JD et al. (2013). Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr 98: 340–348.
69. Lochocka K, Bajerska J, Glapa A, Fidler-Witon E, Nowak JK, Szczapa T et al. (2015). Green tea extract decreases starch digestion and absorption from a test meal in humans: a randomized, placebo-controlled crossover study. Sci Rep 5: 12015. doi:10.1038/srep12015.
70. Loke WM, Hodgson JM, Proudfoot JM, McKinley AJ, Puddey IB, Croft KD (2008). Pure dietary flavonoids quercetin and (−)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr 88: 1018–1025.
71. Long H, Zhu Y, Huang T, Coury LA, Kissinger PT (2001). Identification and determination of polyphenols in tea by liquid chromatography with multichannel electrochemical detection. J Liq Chrom Relat Tech 24: 1105–1114.
72. Luximon-Ramma A, Bahorun T, Crozier A, Zbarsky V, Datla KP, Dexter DT et al. (2005). Characterization of the antioxidant functions of flavonoids and proanthocyanidins in Mauritian black teas. Food Res Int 38: 357–367.
73. Ma S, Wang C, Bai J, Wang X, Li C (2015). Association of tea consumption and the risk of thyroid cancer: a meta-analysis. Int J Clin Exp Med 8: 14345–14351.
74. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81 (1 Suppl): 230S–242S.
75. Mazzanti G, Di Sotto A, Vitalone A (2015). Hepatotoxicity of green tea: an update. Arch Toxicol 89: 1175–1191.
76. Mei Y, Qian F, Wei D, Liu J (2004). Reversal of cancer multidrug resistance by green tea polyphenols. J Pharm Pharmacol 56: 1307–1314.
77. Misaka S, Yatabe J, Müller F, Takano K, Kawabe K, Glaeser H et al. (2014). Green tea ingestion greatly reduces plasma concentrations of nadolol in healthy subjects. Clin Pharmacol Ther 95: 432–438.
78. Mizushina Y, Saito A, Tanaka A, Nakajima N, Kuriyama I, Takemura M et al. (2005). Structural analysis of catechin derivatives as mammalian DNA polymerase inhibitors. Biochem Biophys Res Commun 333: 101–109.
79. Mulder TP, van Platerink CJ, Wijnand Schuyl PJ, van Amelsvoort JM (2001). Analysis of theaflavins in biological fluids using liquid chromatography-electrospray mass spectrometry. Chromatogr B Biomed Sci Appl 760: 271–279.
80. Müller N, Ellinger S, Alteheld B, Ulrich-Merzenich G, Berthold HK, Vetter H et al. (2010). Bolus ingestion of white and green tea increases the concentration of several flavan-3-ols in plasma, but does not affect markers of oxidative stress in healthy non-smokers. Mol Nutr Food Res 54: 1636–1645.
81. Na HK, Surh YJ (2008). Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol 46: 1271–1278.
82. Naftalin RJ, Afzal I, Cunningham P, Halai M, Ross C, Salleh N et al. (2003). Interactions of androgens, green tea catechins and the antiandrogen flutamide with the externalglucose-binding site of the human erythrocyte glucose transporter GLUT1. Br J Pharmacol 140: 487–499.
83. Nguyen TTH, Jung SH, Lee S, Ryu HJ, Kang HK, Moon YH et al. (2012). Inhibitory effects of epigallocatechin gallate and its glucoside on the human intestinal maltase inhibition. Biotechnol Bioproc Eng 17: 966–971.
84. Onakpoya I, Spencer E, Heneghan C, Thompson M (2014). The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 24: 823–836.
85. O'Reilly JD, Mallet AI, McAnlis GT, Young IS, Halliwell B, Sanders TA et al. (2001). Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 73: 1040–1044.
86. Panza VS, Wazlawik E, Ricardo Schütz G, Comin L, Hecht KC, da Silva EL (2008). Consumption of green tea favorably affects oxidative stress markers in weight-trained men. Nutrition 24: 433–442.
87. de Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC (2000). Quantitative analysis of flavan-3-ols in Spanish foodstuffs and beverages. J Agric Food Chem 48: 5331–5337.
88. Passamonti S, Terdoslavich M, Franca R, Vanzo A, Tramer F, Braidot E et al. (2009). Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr Drug Metab 10: 369–394.
89. Pecorari M, Villaño D, Testa MF, Schmid M, Serafini M (2010). Biomarkers of antioxidant status following ingestion of green teas at different polyphenol concentrations and antioxidant capacity in human volunteers. Mol Nutr Food Res 54 (Suppl 2): S278–S283.
90. Pelillo M, Biguzzi B, Bendini A, Gallina Toschi T, Vanzini M et al. (2002). Preliminary investigation into development of HPLC with UV and MS-electrospray detection for the analysis of tea catechins. Food Chem 78: 369–374.
91. Peluso I, Palmery M, Vitalone A (2015b). Green tea and bone marrow transplantation: from antioxidant activity to enzymatic and multidrug-resistance modulation. Crit Rev Food Sci Nutr. doi:10.1080/10408398.2013.826175.
92. Peluso I, Teichner A, Manafikhi H, Palmery M (2015a). Camellia sinensis in asymptomatic hyperuricaemia: a meta-analysis of tea or tea extract effects on uric acid levels. Crit Rev Food Sci Nutr. doi:10.1080/10408398.2014.889653.
93. Peng YH, Sweet DH, Lin SP, Yu CP, Lee Chao PD, Hou YC (2015). Green tea inhibited the elimination of nephro-cardiovascular toxins and deteriorated the renal function in rats with renal failure. Sci Rep 5: 16226. doi:10.1038/srep16226.
94. Price WE, Spitzer JC (1993). Variations in the amounts of individual flavonols in a range of green teas. Food Chem 47: 271–276.
95. Qian F, Wei D, Zhang Q, Yang S (2005). Modulation of P-glycoprotein function and reversal of multidrug resistance by (−)-epigallocatechin gallate in human cancer cells. Biomed Pharmacother 59: 64–69.
96. Rajavelu A, Tulyasheva Z, Jaiswal R, Jeltsch A, Kuhnert N (2011). The inhibition of the mammalian DNA methyltransferase 3a (Dnmt3a) by dietary black tea and coffee polyphenols. BMC Biochem 12: 16. doi:10.1186/1471-2091-12-16.
97. Rechner AR, Wagner E, Buren van L, Put van de F, Wiseman S, Rice-Evans CA (2002). Black tea represents a major source of dietary phenolics among regular tea drinkers. Free Radic Res 36: 1127–1135.
98. Roth M, Timmermann BN, Hagenbuch B (2011). Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos 39: 920–926.
99. Sang S, Lee MJ, Yang I (2008). Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Commun Mass Spectrom 22: 1567–1578.
100. Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, Mahady GB et al. (2008). Safety of green tea extracts : a systematic review by the US Pharmacopeia. Drug Saf 31: 469–484.
101. Schönthal AH (2011). Adverse effects of concentrated green tea extracts. Mol Nutr Food Res 55: 874–885.
102. Sekine T, Miyazaki H, Endou H (2006). Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 290: F251–F261.
103. Serafini M, Del Rio D, Yao DN, Bettuzzi S, Peluso I (2011). Chapter 12. Health benefits of tea. In: Benzie IFF, Wachtel-Galor S (eds). Herbal Medicine: Biomolecular and Clinical Aspects, 2nd edn. CRC Press/Taylor & Francis: Boca Raton (FL).
104. Serafini M, Ghiselli A, Ferro-Luzzi A (1996). (1996) In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 50: 28–32.
105. Shang W, Lu W, Han M, Qiao J (2014). The interactions of anticancer agents with tea catechins: current evidence from preclinical studies. Anticancer Agents Med Chem 14: 1343–1350.
106. Sharpe E, Hua F, Schuckers S, Andreescu S, Bradley R (2016). Effects of brewing conditions on the antioxidant capacity of twenty-four commercial green tea varieties. Food Chem 192: 380–387.
107. Simsek M, Quezada-Calvillo R, Ferruzzi MG, Nichols BL, Hamaker BR (2015). Dietary phenolic compounds selectively inhibit the individual subunits of maltase-glucoamylase and sucrase-isomaltase with the potential of modulating glucose release. J Agric Food Chem 63: 3873–3879.
108. Sone T, Kuriyama S, Nakaya N, Hozawa A, Shimazu T, Nomura K et al. (2011). Randomized controlled trial for an effect of catechin-enriched green tea consumption on adiponectin and cardiovascular disease risk factors. Food Nutr Res 55. doi:10.3402/fnr.v55i0.8326.
109. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44: D1054–D1068.
110. Stewart AJ, Mullen W, Crozier A (2005). On-line high-performance liquid chromatography analysis of the antioxidant activity of phenolic compounds in green and black tea. Mol Nutr Food Res 49: 52–60.
111. Stickel F, Kessebohm K, Weimann R, Seitz HK (2011). Review of liver injury associated with dietary supplements. Liver Int 31: 595–605.
112. Stodt UW, Blauth N, Niemann S, Stark J, Pawar V, Jayaraman S et al. (2014). Investigation of processes in black tea manufacture through model fermentation (oxidation) experiments. J Agric Food Chem 62: 7854–7861.
113. Tanaka T, Matsuo Y, Kouno I (2009). Chemistry of secondary polyphenols produced during processing of tea and selected foods. Int J Mol Sci 11: 14–40.
114. Tang J, Zheng JS, Fang L, Jin Y, Cai W, Li D (2015). Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies. Br J Nutr 114: 673–683.
115. Teschke R, Wolff A, Frenzel C, Schulze J, Eickhoff A (2012). Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 32: 1543–1556.
116. Vaidyanathan JB, Walle T (2003). Cellular uptake and efflux of the tea flavonoid (−)epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 307: 745–752.
117. Valcic S, Burr JA, Timmermann BN, Liebler DC (2000). Antioxidant chemistry of green tea catechins. New oxidation products of (−)-epigallocatechin gallate and (−)-epigallocatechin from their reactions with peroxyl radicals. Chem Res Toxicol 13: 801–810.
118. van Duynhoven J, van der Hooft JJ, van Dorsten FA, Peters S, Foltz M, Gomez-Roldan V et al. (2014). Rapid and sustained systemic circulation of conjugated gut microbial catabolites after single-dose black tea extract consumption. J Proteome Res 13: 2668–2678.
119. van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB (1997). Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 66: 1125–1132.
120. Villaño D, Lettieri-Barbato D, Guadagni F, Schmid M, Serafini M (2012). Effect of acute consumption of oolong tea on antioxidant parameters in healthy individuals. Food Chem 132: 2102–2106.
121. Vischini G, Niscola P, Stefoni A, Farneti F (2011). Increased plasma levels of tacrolimus after ingestion of green tea. Am J Kidney Dis 58: 329.
122. Wang CP, Wang X, Zhang X, Shi YW, Liu L, Kong LD (2010). Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice. J Pharm Pharm Sci 13: 411–427.
123. Wang D, Wang Y, Wan X, Yang CS, Zhang J (2015). Green tea polyphenol (−)-epigallocatechin-3-gallate triggered hepatotoxicity in mice: responses of major antioxidant enzymes and the Nrf2 rescue pathway. Toxicol Appl Pharmacol 283: 65–74.
124. Wang EJ, Barecki-Roach M, Johnson WW (2002). Elevation of P-glycoprotein function by a catechin in green tea. Biochem Biophys Res Commun 297: 412–418.
125. Wang H, Helliwell K, You X (2000). Isocratic elution system for the determination of catechins, caffeine and gallic acid in green tea using HPLC. Food Chem 68: 115–121.
126. Wang S, Sun Z, Dong S, Liu Y, Liu Y (2014). Molecular interactions between (−)-epigallocatechin gallate analogs and pancreatic lipase. PLoS One 9: e111143. doi:10.1371/journal.pone.0111143.eCollection 2014
127. Wang Y, Zhang H, Holmgren A, Tian W, Zhong L (2008). Inhibitory effect of green tea extract and (−)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability. Oncol Rep 20: 1479–1487.
128. Weerawatanakorn M, Hungb WL, Panc MH, Lib S, Lid D, Wand X et al. (2015). Chemistry and health beneficial effects of oolong tea and theasinensins. Food Sci Human Wellness 4: 133–146.
129. Werba JP, Misaka S, Giroli MG, Yamada S, Cavalca V, Kawabe K et al. (2015). Overview of green tea interaction with cardiovascular drugs. Curr Pharm Des 21: 1213–1219.
130. Widlansky ME, Duffy SJ, Hamburg NM, Gokce N, Warden BA, Wiseman S et al. (2005). Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radic Biol Med 38: 499–506.
131. Williamson G, Dionisi F, Renouf M (2011). Flavanols from green tea and phenolic acids from coffee: critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beverages. Mol Nutr Food Res 55: 864–873.
132. Wolfram RM, Oguogho A, Efthimiou Y, Budinsky AC, Sinzinger H (2002). Effect of black tea on (iso-)prostaglandins and platelet aggregation in healthy volunteers. Prostaglandins Leukot Essent Fatty Acids 66: 529–533.
133. Wu X, He W, Yao L, Zhang H, Liu Z, Wang W et al. (2013). Characterization of binding interactions of (−)-epigallocatechin-3-gallate from green tea and lipase. J Agric Food Chem 61: 8829–8835.
134. Yang X, Kong F (2016). Evaluation of the in vitro α-glucosidase inhibitory activity of green tea polyphenols and different tea types. J Sci Food Agric 96: 777–782.
135. Yiannakopoulou EC (2015). Targeting DNA methylation with green tea catechins. Pharmacology 95: 111–116.
136. Yuda N, Tanaka M, Suzuki M, Asano Y, Ochi H, Iwatsuki K (2012). Polyphenols extracted from black tea (Camellia sinensis) residue by hot-compressed water and their inhibitory effect on pancreatic lipase in vitro. J Food Sci 77: H254–H261.
137. Zeng JL, Li ZH, Wang ZC, Zhang HL (2014). Green tea consumption and risk of pancreatic cancer: a meta-analysis. Nutrients 6: 4640–4650.
138. Zhang A, Chan PT, Luk YS, Ho WKK, Chen ZY (1997). Inhibitory effect of jasmine green tea epicatechin isomers on LDL-oxidation. J Nutr Biochem 8: 334–340.
139. Zhang Y, Hays A, Noblett A, Thapa M, Hua DH, Hagenbuch B (2013). Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives. J Nat Prod 76: 368–373.
140. Zhao Y, Asimi S, Wu K, Zheng J, Li D (2015). Black tea consumption and serum cholesterol concentration: systematic review and meta-analysis of randomized controlled trials. Clin Nutr 34: 612–619.
141. Zheng XX, Xu YL, Li SH, Hui R, Wu YJ, Huang XH (2013). Effects of green tea catechins with or without caffeine on glycemic control in adults: a meta-analysis of randomized controlled trials. Am J Clin Nutr 97: 750–762.
142. Zheng XX, Xu YL, Li SH, Liu XX, Hui R, Huang XH (2011). Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr 94: 601–610.
143. Zhou Q, Li H, Zhou JG, Ma Y, Wu T, Ma H (2016). Green tea, black tea consumption and risk of endometrial cancer: a systematic review and meta-analysis. Arch Gynecol Obstet 293: 143–155.
144. Zhu G, Hua J, Wang Z, She F, Chen Y (2015). Tea consumption and risk of gallbladder cancer: a meta-analysis of epidemiological studies. Mol Clin Oncol 3: 613–618.